NCT Number: NCT00143195
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
The objective of study is to compare the anti-ischemic efficacy and safety profiles of once daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and symptomatic myocardial ischemia
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Pfizer Investigational Site, Athens, Attica, Greece
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Outpatients > =18 years of age with diagnosed clinically stable angina pectoris
Exclusion criteria
- Patients with congestive heart failure, clinically significant cardiovascular disease, standing systolic blood pressure of less than 100mmHg, concomitant anti-anginal therapies similar to sublingual NTG
Treatment and study plan
iso- 5 - mononitrate
DrugBlood tests
ProcedureExercise Stress Test
ProcedurePrimary outcomes
-
Evaluate the time to 1mm ST depression
Secondary outcomes
-
The number of patients experiencing angina attacks The frequency of hospitalizations due to angina attacks Time to onset of 1mm ST segment depression Total external workload performed Safety
Sponsors and collaborators
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Registry information
Official study title
Open Label Study Comparing Amlodipine vs Long-acting Nitrates in Patients With Chronic Stable Angina.
Acronym: ANISSA
Important dates
- Study start
- 2001
- Study completion
- 2005
- First posted
- Sep 2, 2005
- Registry last updated
- Jan 28, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
CES1 Carriers in the PAPI Study
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsSystematic Post-Implementation Evaluation of Stents
NCT05584280
Cardiovascular Diseases, Heart Diseases
Gothenburg, Sweden
View Trial DetailsSecondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
NCT02694185
Behavior, Cardiovascular Diseases
San Francisco, California, United States
View Trial DetailsHeart-brain-axis and Psychosocial Stress
NCT06345573
Behavior, Behavioral Symptoms
Zurich, Canton of Zurich, Switzerland
View Trial Details